With oil and oil stocks at all time high, healthcare stocks are out of favor. Maybe it is time to pick up some, as some Gurus are already doing. Edward Owens, one of the best healthcare investor, picked some of his favorite. These are the details.
Edward Owens buys Aetna Inc., WellCare Health Plans Inc., Davita Inc., sells Axcan Pharma Inc. during the 3-months ended 03/31/2008, according to the most recent filings of his investment company, Vanguard Health Care Fund. Edward Owens owns 79 stocks with a total value of $21311.4 billion. These are the details of the buys and sells.
New Purchases: AET, DVA, WCG,
Added Positions: MRK, PDLI, SGP, UNH, WAG, WLP,
Reduced Positions: JNJ, NVO, UNM,
Sold Out:
For the details of Edward Owens's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Edward+Owens
Added: Merck & Co. Inc. (MRK, Financial)
Edward Owens added to his holdings in Merck & Co. Inc. by 36.77%. His purchase prices were between $40.97 and $60.02, with an estimated average price of $47.2. The impact to his portfolio due to this purchase was 0.64%. His holdings were 13,391,200 shares as of 03/31/2008.
Merck & Co., Inc. provides various products for human and animal health in the United States and internationally. The company's Pharmaceutical segment includes human health pharmaceutical products, such as therapeutic and preventive agents. Merck & Co. Inc. has a market cap of $83.99 billion; its shares were traded at around $39.13 with a P/E ratio of 17.59 and P/S ratio of 3.52. The dividend yield of Merck & Co. Inc. stocks is 3.8%.
Added: WellPoint Inc. (WLP, Financial)
Edward Owens added to his holdings in WellPoint Inc. by 71.75%. His purchase prices were between $43.23 and $87.63, with an estimated average price of $70.1. The impact to his portfolio due to this purchase was 0.58%. His holdings were 6,702,400 shares as of 03/31/2008.
WellPoint, Inc., through its subsidiaries, operates as a commercial health benefits company in the United States. It offers various network-based managed care plans to the large and small employer, individual, Medicaid, and senior markets. WellPoint Inc. has a market cap of $28.25 billion; its shares were traded at around $53.69 with a P/E ratio of 9.94 and P/S ratio of 0.45.
Added: ScheringPlough Corp. (SGP, Financial)
Edward Owens added to his holdings in ScheringPlough Corp. by 9.76%. His purchase prices were between $18.69 and $27.54, with an estimated average price of $21.2. The impact to his portfolio due to this purchase was 0.35%. His holdings were 57,742,800 shares as of 03/31/2008.
Schering-Plough Corporation discovers, develops, manufactures, and sells pharmaceuticals worldwide. It operates in three segments: Human Prescription Pharmaceuticals, Animal Health, and Consumer Health Care. ScheringPlough Corp. has a market cap of $31.31 billion; its shares were traded at around $19.31 with P/S ratio of 2.17. The dividend yield of ScheringPlough Corp. stocks is 1.3%.
Added: UnitedHealth Group Inc. (UNH, Financial)
Edward Owens added to his holdings in UnitedHealth Group Inc. by 14.11%. His purchase prices were between $34.37 and $55.95, with an estimated average price of $46.8. The impact to his portfolio due to this purchase was 0.14%. His holdings were 6,961,000 shares as of 03/31/2008.
UnitedHealth Group Incorporated provides healthcare services in the United States. The company's Health Care Services segment offers consumer-oriented health benefit plans and services; administrative and other management services to customers. UnitedHealth Group Inc. has a market cap of $41.97 billion; its shares were traded at around $34.16 with a P/E ratio of 9.63 and P/S ratio of 0.55. The dividend yield of UnitedHealth Group Inc. stocks is 0.1%.
Added: Walgreen Company (WAG, Financial)
Edward Owens added to his holdings in Walgreen Company by 5.53%. His purchase prices were between $33.52 and $37.33, with an estimated average price of $35.4. The impact to his portfolio due to this purchase was 0.11%. His holdings were 11,450,000 shares as of 03/31/2008.
Walgreen Co. operates a chain of drugstores in the United States. These drugstores sell prescription and non-prescription drugs, and general merchandise. Walgreen Company has a market cap of $34.94 billion; its shares were traded at around $35.28 with a P/E ratio of 16.80 and P/S ratio of 0.63. The dividend yield of Walgreen Company stocks is 1%.
Added: PDL BioPharma Inc. (PDLI, Financial)
Edward Owens added to his holdings in PDL BioPharma Inc. by 31.72%. His purchase prices were between $6.69 and $11.3, with an estimated average price of $9.6. The impact to his portfolio due to this purchase was 0.01%. His holdings were 830,500 shares as of 03/31/2008.
PDL BioPharma, Inc., a biopharmaceutical company, engages in the discovery and development of antibodies for oncology and immunologic diseases worldwide. PDL BioPharma Inc. has a market cap of $1.15 billion; its shares were traded at around $9.76 with P/S ratio of 4.43.
New Purchase: Aetna Inc. (AET, Financial)
Edward Owens initiated holdings in Aetna Inc.. His purchase prices were between $42.54 and $58.41, with an estimated average price of $50.3. The impact to his portfolio due to this purchase was 0.12%. His holdings were 600,000 shares as of 03/31/2008.
Aetna, Inc. operates as a diversified health care benefits company primarily in the United States and Canada. The company provides health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life, etc. Aetna Inc. has a market cap of $21.65 billion; its shares were traded at around $44.65 with a P/E ratio of 12.71 and P/S ratio of 0.75. The dividend yield of Aetna Inc. stocks is 0.1%.
New Purchase: WellCare Health Plans Inc. (WCG, Financial)
Edward Owens initiated holdings in WellCare Health Plans Inc.. His purchase prices were between $36.85 and $54.11, with an estimated average price of $46. The impact to his portfolio due to this purchase was 0.09%. His holdings were 500,000 shares as of 03/31/2008.
WellCare Health Plans, Inc. provides managed care services exclusively for government-sponsored healthcare programs, focusing on Medicaid and Medicare in the United States. WellCare Health Plans Inc. has a market cap of $2.16 billion; its shares were traded at around $51.87 with a P/E ratio of 11.93 and P/S ratio of 0.45.
New Purchase: Davita Inc. (DVA, Financial)
Edward Owens initiated holdings in Davita Inc.. His purchase prices were between $43.87 and $59.08, with an estimated average price of $51. The impact to his portfolio due to this purchase was 0.05%. His holdings were 204,600 shares as of 03/31/2008.
DaVita, Inc. provides dialysis services for patients suffering from chronic kidney failure, which is known as end stage renal disease (ESRD) in the United States. Davita Inc. has a market cap of $5.44 billion; its shares were traded at around $51.97 with a P/E ratio of 14.29 and P/S ratio of 1.01.
Reduced: Johnson & Johnson (JNJ, Financial)
Edward Owens reduced to his holdings in Johnson & Johnson by 24.24%. His sale prices were between $61.51 and $67.43, with an estimated average price of $63.6. The impact to his portfolio due to this sale was 0.61%. Edward Owens still held 2,500,000 shares as of 03/31/2008.
Johnson & Johnson has a market cap of $185.24 billion; its shares were traded at around $65.73 with a P/E ratio of 16.40 and P/S ratio of 2.99. The dividend yield of Johnson & Johnson stocks is 2.8%.
Reduced: NovoNordisk A/S (NVO, Financial)
Edward Owens reduced to his holdings in NovoNordisk A/S by 35.71%. His sale prices were between $57.92 and $67.58, with an estimated average price of $63.9. The impact to his portfolio due to this sale was 0.21%. Edward Owens still held 900,000 shares as of 03/31/2008.
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products. It operates in two segments, Diabetes Care and Biopharmaceuticals. NovoNordisk A/S has a market cap of $42.08 billion; its shares were traded at around $67.77 with a P/E ratio of 22.97 and P/S ratio of 4.76. The dividend yield of NovoNordisk A/S stocks is 1.3%.
Reduced: Unum Group (UNM, Financial)
Edward Owens reduced to his holdings in Unum Group by 66.27%. His sale prices were between $20.48 and $24.01, with an estimated average price of $22.1. The impact to his portfolio due to this sale was 0.02%. Edward Owens still held 356,300 shares as of 03/31/2008.
Unum Group provides group and individual disability products primarily in the United States and the United Kingdom. It also provides a portfolio of other insurance products, including long-term care insurance, life insurance, etc. Unum Group has a market cap of $8.24 billion; its shares were traded at around $23.79 with a P/E ratio of 12.79 and P/S ratio of 0.80. The dividend yield of Unum Group stocks is 1.2%.
Edward Owens buys Aetna Inc., WellCare Health Plans Inc., Davita Inc., sells Axcan Pharma Inc. during the 3-months ended 03/31/2008, according to the most recent filings of his investment company, Vanguard Health Care Fund. Edward Owens owns 79 stocks with a total value of $21311.4 billion. These are the details of the buys and sells.
New Purchases: AET, DVA, WCG,
Added Positions: MRK, PDLI, SGP, UNH, WAG, WLP,
Reduced Positions: JNJ, NVO, UNM,
Sold Out:
For the details of Edward Owens's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Edward+Owens
Added: Merck & Co. Inc. (MRK, Financial)
Edward Owens added to his holdings in Merck & Co. Inc. by 36.77%. His purchase prices were between $40.97 and $60.02, with an estimated average price of $47.2. The impact to his portfolio due to this purchase was 0.64%. His holdings were 13,391,200 shares as of 03/31/2008.
Merck & Co., Inc. provides various products for human and animal health in the United States and internationally. The company's Pharmaceutical segment includes human health pharmaceutical products, such as therapeutic and preventive agents. Merck & Co. Inc. has a market cap of $83.99 billion; its shares were traded at around $39.13 with a P/E ratio of 17.59 and P/S ratio of 3.52. The dividend yield of Merck & Co. Inc. stocks is 3.8%.
Added: WellPoint Inc. (WLP, Financial)
Edward Owens added to his holdings in WellPoint Inc. by 71.75%. His purchase prices were between $43.23 and $87.63, with an estimated average price of $70.1. The impact to his portfolio due to this purchase was 0.58%. His holdings were 6,702,400 shares as of 03/31/2008.
WellPoint, Inc., through its subsidiaries, operates as a commercial health benefits company in the United States. It offers various network-based managed care plans to the large and small employer, individual, Medicaid, and senior markets. WellPoint Inc. has a market cap of $28.25 billion; its shares were traded at around $53.69 with a P/E ratio of 9.94 and P/S ratio of 0.45.
Added: ScheringPlough Corp. (SGP, Financial)
Edward Owens added to his holdings in ScheringPlough Corp. by 9.76%. His purchase prices were between $18.69 and $27.54, with an estimated average price of $21.2. The impact to his portfolio due to this purchase was 0.35%. His holdings were 57,742,800 shares as of 03/31/2008.
Schering-Plough Corporation discovers, develops, manufactures, and sells pharmaceuticals worldwide. It operates in three segments: Human Prescription Pharmaceuticals, Animal Health, and Consumer Health Care. ScheringPlough Corp. has a market cap of $31.31 billion; its shares were traded at around $19.31 with P/S ratio of 2.17. The dividend yield of ScheringPlough Corp. stocks is 1.3%.
Added: UnitedHealth Group Inc. (UNH, Financial)
Edward Owens added to his holdings in UnitedHealth Group Inc. by 14.11%. His purchase prices were between $34.37 and $55.95, with an estimated average price of $46.8. The impact to his portfolio due to this purchase was 0.14%. His holdings were 6,961,000 shares as of 03/31/2008.
UnitedHealth Group Incorporated provides healthcare services in the United States. The company's Health Care Services segment offers consumer-oriented health benefit plans and services; administrative and other management services to customers. UnitedHealth Group Inc. has a market cap of $41.97 billion; its shares were traded at around $34.16 with a P/E ratio of 9.63 and P/S ratio of 0.55. The dividend yield of UnitedHealth Group Inc. stocks is 0.1%.
Added: Walgreen Company (WAG, Financial)
Edward Owens added to his holdings in Walgreen Company by 5.53%. His purchase prices were between $33.52 and $37.33, with an estimated average price of $35.4. The impact to his portfolio due to this purchase was 0.11%. His holdings were 11,450,000 shares as of 03/31/2008.
Walgreen Co. operates a chain of drugstores in the United States. These drugstores sell prescription and non-prescription drugs, and general merchandise. Walgreen Company has a market cap of $34.94 billion; its shares were traded at around $35.28 with a P/E ratio of 16.80 and P/S ratio of 0.63. The dividend yield of Walgreen Company stocks is 1%.
Added: PDL BioPharma Inc. (PDLI, Financial)
Edward Owens added to his holdings in PDL BioPharma Inc. by 31.72%. His purchase prices were between $6.69 and $11.3, with an estimated average price of $9.6. The impact to his portfolio due to this purchase was 0.01%. His holdings were 830,500 shares as of 03/31/2008.
PDL BioPharma, Inc., a biopharmaceutical company, engages in the discovery and development of antibodies for oncology and immunologic diseases worldwide. PDL BioPharma Inc. has a market cap of $1.15 billion; its shares were traded at around $9.76 with P/S ratio of 4.43.
New Purchase: Aetna Inc. (AET, Financial)
Edward Owens initiated holdings in Aetna Inc.. His purchase prices were between $42.54 and $58.41, with an estimated average price of $50.3. The impact to his portfolio due to this purchase was 0.12%. His holdings were 600,000 shares as of 03/31/2008.
Aetna, Inc. operates as a diversified health care benefits company primarily in the United States and Canada. The company provides health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life, etc. Aetna Inc. has a market cap of $21.65 billion; its shares were traded at around $44.65 with a P/E ratio of 12.71 and P/S ratio of 0.75. The dividend yield of Aetna Inc. stocks is 0.1%.
New Purchase: WellCare Health Plans Inc. (WCG, Financial)
Edward Owens initiated holdings in WellCare Health Plans Inc.. His purchase prices were between $36.85 and $54.11, with an estimated average price of $46. The impact to his portfolio due to this purchase was 0.09%. His holdings were 500,000 shares as of 03/31/2008.
WellCare Health Plans, Inc. provides managed care services exclusively for government-sponsored healthcare programs, focusing on Medicaid and Medicare in the United States. WellCare Health Plans Inc. has a market cap of $2.16 billion; its shares were traded at around $51.87 with a P/E ratio of 11.93 and P/S ratio of 0.45.
New Purchase: Davita Inc. (DVA, Financial)
Edward Owens initiated holdings in Davita Inc.. His purchase prices were between $43.87 and $59.08, with an estimated average price of $51. The impact to his portfolio due to this purchase was 0.05%. His holdings were 204,600 shares as of 03/31/2008.
DaVita, Inc. provides dialysis services for patients suffering from chronic kidney failure, which is known as end stage renal disease (ESRD) in the United States. Davita Inc. has a market cap of $5.44 billion; its shares were traded at around $51.97 with a P/E ratio of 14.29 and P/S ratio of 1.01.
Reduced: Johnson & Johnson (JNJ, Financial)
Edward Owens reduced to his holdings in Johnson & Johnson by 24.24%. His sale prices were between $61.51 and $67.43, with an estimated average price of $63.6. The impact to his portfolio due to this sale was 0.61%. Edward Owens still held 2,500,000 shares as of 03/31/2008.
Johnson & Johnson has a market cap of $185.24 billion; its shares were traded at around $65.73 with a P/E ratio of 16.40 and P/S ratio of 2.99. The dividend yield of Johnson & Johnson stocks is 2.8%.
Reduced: NovoNordisk A/S (NVO, Financial)
Edward Owens reduced to his holdings in NovoNordisk A/S by 35.71%. His sale prices were between $57.92 and $67.58, with an estimated average price of $63.9. The impact to his portfolio due to this sale was 0.21%. Edward Owens still held 900,000 shares as of 03/31/2008.
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products. It operates in two segments, Diabetes Care and Biopharmaceuticals. NovoNordisk A/S has a market cap of $42.08 billion; its shares were traded at around $67.77 with a P/E ratio of 22.97 and P/S ratio of 4.76. The dividend yield of NovoNordisk A/S stocks is 1.3%.
Reduced: Unum Group (UNM, Financial)
Edward Owens reduced to his holdings in Unum Group by 66.27%. His sale prices were between $20.48 and $24.01, with an estimated average price of $22.1. The impact to his portfolio due to this sale was 0.02%. Edward Owens still held 356,300 shares as of 03/31/2008.
Unum Group provides group and individual disability products primarily in the United States and the United Kingdom. It also provides a portfolio of other insurance products, including long-term care insurance, life insurance, etc. Unum Group has a market cap of $8.24 billion; its shares were traded at around $23.79 with a P/E ratio of 12.79 and P/S ratio of 0.80. The dividend yield of Unum Group stocks is 1.2%.
